Showing results (371-380 of 551) with videos related to
Sort By:
Pageof 56
Mededportal : the Journal of Teaching and Learning Resources|May 2, 2022
Standardizing Quality of Virtual Urgent Care: Using Standardized Patients in a Unique Experiential Onboarding ProgramDaniel J Sartori, Viraj Lakdawala, Heather B Levitt, et al.Diabetes, Obesity & Metabolism|July 2, 2010
Patient-reported outcomes following treatment with the human GLP-1 analogue liraglutide or glimepiride in monotherapy: results from a randomized controlled trial in patients with type 2 diabetesB W Bode, M A Testa, M Magwire, et al.Journal of Hypertension|December 30, 1998
Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine in hypertensive patients in Spain. Gastrointestinal Therapeutic SystemM A Testa, R R Turner, D C Simonson, et al.The Journal of Clinical Psychiatry|April 7, 1999
The effects of venlafaxine on social activity level in depressed outpatientsW R Lenderking, H Tennen, J F Nackley, et al.La Clinica Terapeutica|June 15, 1999
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II studyV Gebbia, A Testa, N Borsellino, et al.Journal of the American Society of Nephrology : JASN|September 7, 1999
Effect of protein A immunoadsorption in nephrotic syndrome of various etiologiesV L Esnault, D Besnier, A Testa, et al.Diabetes Care|August 3, 2019
Lifestyle Counseling and Long-term Clinical Outcomes in Patients With DiabetesHuabing Zhang, Saveli I Goldberg, Naoshi Hosomura, et al.Nephron|January 1, 1988
Treatment of severe renovascular hypertension by percutaneous transluminal renal angioplasty in patients with solitary functioning kidney. Effects on blood pressure and renal functionD Russo, V Iaccarino, G Conte, et al.Journal of General Internal Medicine|August 6, 2014
Reliability and validity of the Haitian Creole PHQ-9Linda G Marc, Whitney R Henderson, Astrid Desrosiers, et al.European Review for Medical and Pharmacological Sciences|January 28, 2021
Real-world effectiveness and safety of Guselkumab for the treatment of psoriasis: a 6-month prospective study in a series of psoriatic patientsG Malara, C Trifirò, A Bartolotta, et al.Pageof 56